QBE North America announced today the launch of a Life Sciences product offering designed to address the complex and evolving risks faced by medical product developers, manufacturers and distributors.

“Life sciences companies face a unique and fast-changing risk landscape,” said Lisa McCormack, vice president, underwriting leader – Life Sciences, QBE North America. “Our new offering is tailored to meet the specific coverage needs of these businesses as they continue to innovate and advance health care.”

The Life Sciences product provides liability protection for a wide range of classifications, including clinical trials, dental and medical devices, personal care, specialty pharmaceuticals, animal health products, and more.

QBE offers primary and excess Life Sciences liability coverages such as:

• Products completed operations
• Clinical trial liability
• Errors and omissions (E&O)
• General liability
• Healthcare professional liability

“Our new Life Sciences product offers flexible and comprehensive coverage,” said John Livatino, senior vice president, head of Healthcare Liability, QBE North America. “By leveraging our suite of Healthcare Liability solutions, we can also expand coverage for life sciences companies to include areas like medical professional liability and technology. Whether it’s Life Sciences, Digital Health or Miscellaneous Medical Liability, we’re committed to providing a comprehensive insurance solution to these organizations.”

The launch expands QBE’s Healthcare Liability portfolio following the introduction of its Miscellaneous Medical Liability product in 2024. That offering includes coverages for professional liability, physical & sexual misconduct liability, general liability, employee benefits liability, E&O, tech & media liability and excess/umbrella.

More information about QBE’s Life Sciences product is available at qbe.com/us/healthcare-liability.